Abstract
Glioblastoma multiforme (GBM) is the most common form of primary brain tumor in adults, often characterized by poor survival. Glioma-initiating cells (GiCs) are defined by their extensive self-renewal, differentiation, and tumor initiation properties. GiCs are known to be involved in tumor growth and recurrence, and in resistance to conventional treatments. One strategy to efficiently target GiCs in GBM consists in suppressing their stemness and consequently their tumorigenic properties. In this study, we show that the miR-302-367 cluster is strongly induced during serum-mediated stemness suppression. Stable miR-302-367 cluster expression is sufficient to suppress the stemness signature, self-renewal, and cell infiltration within a host brain tissue, through inhibition of the CXCR4 pathway. Furthermore, inhibition of CXCR4 leads to the disruption of the sonic hedgehog (SHH)-GLI-NANOG network, which is involved in self-renewal and expression of the embryonic stem cell-like signature. In conclusion, we demonstrated that the miR-302-367 cluster is able to efficiently trigger a cascade of inhibitory events leading to the disruption of GiCs stem-like and tumorigenic properties.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
Abbreviations
- GBM:
-
Glioblastoma multiforme
- MGMT:
-
O-6 methylguanine-DNA methyltransferase
- GICS:
-
glioma-initiating cells
- miRNA:
-
micro ribonucleic acid
- SHH:
-
sonic hedgehog
- EGF:
-
epidermal growth factor
- bFGF:
-
basic fibroblast growth factor
- GFAP:
-
glial fibrillary acidic protein
- IPS:
-
inducible pluripotent stem cells
References
Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005; 352: 987–996.
Wen PY, Kesari S . Malignant gliomas in adults. N Engl J Med 2008; 359: 492–507.
Shannon RP, Sayre JW, Sayre JJ . Patterns of care for adults with malignant glioma. Jama 2005; 293: 2469–2470; author reply 2470.
Hegi ME, Diserens AC, Godard S, Dietrich PY, Regli L, Ostermann S et al. Clinical trial substantiates the predictive value of O-6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomide. Clin Cancer Res 2004; 10: 1871–1874.
Germano I, Swiss V, Casaccia P . Primary brain tumors, neural stem cell, and brain tumor cancer cells: where is the link? Neuropharmacology 2010; 58: 903–910.
Passegue E, Jamieson CH, Ailles LE, Weissman IL . Normal and leukemic hematopoiesis: are leukemias a stem cell disorder or a reacquisition of stem cell characteristics? Proc Natl Acad Sci USA 2003; 100 (Suppl 1): 11842–11849.
Smalley M, Ashworth A . Stem cells and breast cancer: a field in transit. Nat Rev Cancer 2003; 3: 832–844.
Wu W 2010 Patents related to cancer stem cell research. Recent Pat DNA Gene Seq 4: 40–45.
Visvader JE, Lindeman GJ . Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer 2008; 8: 755–768.
Piccirillo SG, Vescovi AL . Bone morphogenetic proteins regulate tumorigenicity in human glioblastoma stem cells. Ernst Schering Found Symp Proc 2006; 5: 59–81.
Rao M . Conserved and divergent paths that regulate self-renewal in mouse and human embryonic stem cells. Dev Biol 2004; 275: 269–286.
Wang Y, Medvid R, Melton C, Jaenisch R, Blelloch R . DGCR8 is essential for microRNA biogenesis and silencing of embryonic stem cell self-renewal. Nat Genet 2007; 39: 380–385.
Zbinden M, Duquet A, Lorente-Trigos A, Ngwabyt SN, Borges I, Ruiz IAA . NANOG regulates glioma stem cells and is essential in vivo acting in a cross-functional network with GLI1 and p53. Embo J 2010; 29: 2659–2674.
Patru C, Romao L, Varlet P, Coulombel L, Raponi E, Cadusseau J et al. CD133, CD15/SSEA-1, CD34 or side populations do not resume tumor-initiating properties of long-term cultured cancer stem cells from human malignant glio-neuronal tumors. BMC Cancer 2010; 10: 66.
Clement V, Sanchez P, de Tribolet N, Radovanovic I, Ruiz i Altaba A . HEDGEHOG-GLI1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity. Curr Biol 2007; 17: 165–172.
Ehtesham M, Stevenson CB, Thompson RC . Preferential expression of chemokine receptor CXCR4 by highly malignant human gliomas and its association with poor patient survival. Neurosurgery 2008; 63: E820; author reply E820.
do Carmo A, Patricio I, Cruz MT, Carvalheiro H, Oliveira CR, Lopes MC . CXCL12/CXCR4 promotes motility and proliferation of glioma cells. Cancer Biol Ther 2010; 9: 56–65.
Shi Y, Sun G, Zhao C, Stewart R . Neural stem cell self-renewal. Crit Rev Oncol Hematol 2008; 65: 43–53.
Lai K, Kaspar BK, Gage FH, Schaffer DV . Sonic hedgehog regulates adult neural progenitor proliferation in vitro and in vivo. Nat Neurosci 2003; 6: 21–27.
Card DA, Hebbar PB, Li L, Trotter KW, Komatsu Y, Mishina Y et al. Oct4/Sox2-regulated miR-302 targets cyclin D1 in human embryonic stem cells. Mol Cell Biol 2008; 28: 6426–6438.
Ben-Porath I, Thomson MW, Carey VJ, Ge R, Bell GW, Regev A et al. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet 2008; 40: 499–507.
Alcock J, Sottile V . Dynamic distribution and stem cell characteristics of Sox1-expressing cells in the cerebellar cortex. Cell Res 2009; 19: 1324–1333.
Wegner M, Stolt CC . From stem cells to neurons and glia: a Soxist's view of neural development. Trends Neurosci 2005; 28: 583–588.
Palma V, Lim DA, Dahmane N, Sanchez P, Brionne TC, Herzberg CD et al. Sonic hedgehog controls stem cell behavior in the postnatal and adult brain. Development 2005; 132: 335–344.
Elkouris M, Balaskas N, Poulou M, Politis PK, Panayiotou E, Malas S. et al. 2011 Sox1 maintains the undifferentiated state of cortical neural progenitor cells via the suppression of Prox1-mediated cell cycle exit and neurogenesis. Stem Cells 29: 89–98.
Salcido CD, Larochelle A, Taylor BJ, Dunbar E, Varticovski L . Molecular characterisation of side population cells with cancer stem cell-like characteristics in small-cell lung cancer. Br J Cancer 2010; 102: 1636–1644.
Wright MH, Calcagno AM, Salcido CD, Carlson MD, Ambudkar SV, Varticovski L . Brca1 breast tumors contain distinct CD44+/CD24- and CD133+ cells with cancer stem cell characteristics. Breast Cancer Res 2008; 10: R10.
Rosa A, Spagnoli FM, Brivanlou AH . The miR-430/427/302 family controls mesendodermal fate specification via species-specific target selection. Dev Cell 2009; 16: 517–527.
Barroso-del Jesus A, Lucena-Aguilar G, Menendez P . The miR-302-367 cluster as a potential stemness regulator in ESCs. Cell Cycle 2009; 8: 394–398.
Lin SL, Chang DC, Chang-Lin S, Lin CH, Wu DT, Chen DT et al. Mir-302 reprograms human skin cancer cells into a pluripotent ES-cell-like state. Rna 2008; 14: 2115–2124.
Barroso-delJesus A, Romero-Lopez C, Lucena-Aguilar G, Melen GJ, Sanchez L, Ligero G et al. Embryonic stem cell-specific miR302-367 cluster: human gene structure and functional characterization of its core promoter. Mol Cell Biol 2008; 28: 6609–6619.
Teicher BA, Fricker SP . CXCL12 (SDF-1)/CXCR4 pathway in cancer. Clin Cancer Res 2010; 16: 2927–2931.
Ehtesham M, Mapara KY, Stevenson CB, Thompson RC . CXCR4 mediates the proliferation of glioblastoma progenitor cells. Cancer Lett 2009; 274: 305–312.
Dougherty JD, Garcia AD, Nakano I, Livingstone M, Norris B, Polakiewicz R et al. PBK/TOPK, a proliferating neural progenitor-specific mitogen-activated protein kinase kinase. J Neurosci 2005; 25: 10773–10785.
Park JH, Lin ML, Nishidate T, Nakamura Y, Katagiri T . PDZ-binding kinase/T-LAK cell-originated protein kinase, a putative cancer/testis antigen with an oncogenic activity in breast cancer. Cancer Res 2006; 66: 9186–9195.
Hans F, Dimitrov S . Histone H3 phosphorylation and cell division. Oncogene 2001; 20: 3021–3027.
Kioi M, Vogel H, Schultz G, Hoffman RM, Harsh GR, Brown JM . Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice. J Clin Invest 2010; 120: 694–705.
Acknowledgements
This work was supported by grants from Association pour la Recherche sur le Cancer (subvention 3161), Association Sauvons Laura, Agence Nationale pour la Recherche (ANR jeune chercheur), INSERM, UNSA, OSEO/VALORPACA. We thank Dr. Rassoulzadegan's lab (Inserm U636, F-06108 Nice, France) for their contribution in our organotypic culture model of mouse brain.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Edited by R De Maria
Supplementary Information accompanies the paper on Cell Death and Differentiation website
Rights and permissions
About this article
Cite this article
Fareh, M., Turchi, L., Virolle, V. et al. The miR 302-367 cluster drastically affects self-renewal and infiltration properties of glioma-initiating cells through CXCR4 repression and consequent disruption of the SHH-GLI-NANOG network. Cell Death Differ 19, 232–244 (2012). https://doi.org/10.1038/cdd.2011.89
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/cdd.2011.89
Keywords
This article is cited by
-
Current understanding of epigenetics mechanism as a novel target in reducing cancer stem cells resistance
Clinical Epigenetics (2021)
-
CXCR4 uses STAT3-mediated slug expression to maintain radioresistance of non-small cell lung cancer cells: emerges as a potential prognostic biomarker for lung cancer
Cell Death & Disease (2021)
-
MicroRNA302-367-PI3K-PTEN-AKT-mTORC1 pathway promotes the development of cardiac hypertrophy through controlling autophagy
In Vitro Cellular & Developmental Biology - Animal (2020)
-
miRNA-302s may act as oncogenes in human testicular germ cell tumours
Scientific Reports (2019)
-
miR-302a inhibits human HepG2 and SMMC-7721 cells proliferation and promotes apoptosis by targeting MAP3K2 and PBX3
Scientific Reports (2019)
